Blue Horseshoe Stocks: Options Review


Options Review

We dedicated yesterday’s premarket newsletters to our Special Report, so we wanted to circle back this morning to go over a couple of options ideas we submitted to our readers on Tuesday morning.

We had identified plays in the ULTA and MKC options chains following a Form-4 Alert and an earnings report, respectively, and in both cases we met with fantastic multi-bag gain opportunities. Here were the total possible profits on the table:

ULTA 11/01 $260-265 Calls
$260 Calls – Range: 4.00-13.30 – Max Gain: 233%
$262.50 Calls – Range: 2.60-12.50 – Max Gain: 381%
$265 Calls – Range: 2.80-11.25 – Max Gain: 302%
_____

MKC Weekly $155-160 Calls

$155 Calls – Range: 5.58-13.58 – Max Gain: 143%
$160 Calls – Range: 2.82-9.12 – Max Gain: 223%
_____

Fresh Options Idea:
PEP Weekly $134-136 Calls 



American Renal Associates Holdings, Inc. ARA

We also want to place ARA on watch as a possible bottom bounce play. The stock has never been much lower than where it’s currently trading, has a recently history of sharp spikes, and indications that a significant rebound could be on the way. We’ll keep an eye peeled for such activity over the next several sessions.


Extended Watchlist:
CBNT, CLVS, ARQL, BIOC, HYRE, MEET

Blue Horseshoe Stocks: AAPL Options & More

Apple, Inc. AAPL

Our more seasoned readers will remember a time when we almost exclusively talked about microcaps trading on the OTC, but a few years ago, we decided to go to where the real money was, and have since focused primarily on quick-strike options trading opportunities. It was with AAPL that we got our sea legs in options trading, and it has been a heck of a ride since.

We’re coming back to AAPL once again to use the spike in trading activity associated with the company’s Q3 earnings beat to try to score some nice gains. The stock is gapping up into blue skies here in the premarket after rising to record high valuation, just a stone’s throw from a TRILLION dollar market cap!

We’re going to be monitoring the AAPL Weekly $195-200 Calls to try to score some nice chances this midweek.


SodaStream International, Inc. SODA

Speaking of earnings beats, SodaStream just reported on its Q2 figures, and is shining in the premarket on the heels of a strong showing and boosted guidance for the future.

We’ll look to take advantage of this situation as well, by earmarking the SODA Weekly $99-105 Calls for observation this morning.


Whirlpool Corp WHR

On Friday, we selected a range of options in the Whirlpool chain, the 08/03 $129-131 Calls, and we wanted to swing back around this morning in order to go over the success we had with those plays.
.
In just a few days time, each set of contracts has made considerable multi-bag moves, which have been as follows:

$129 Calls – Range: .96-2.05 – Max Gain: 114%
$130 Calls – Range: .68-2.20 – Max Gain: 224%
$131 Calls – Range: .55-1.27 – Max Gain: 131%

Judging by the activity thus far, we’re going to want to continue to stay on top of these calls for the remainder of the week.


Extended Watchlist:
MEET, ATTU, MTOR, CLRB, FATE, SNES, RGSE, TROV

Blue Horseshoe Stocks: MJMJ, MEET Recaps & More

MeetMe, Inc. MEET

Yesterday
we tagged MEET for the first time since last year, and our timing in turning our attention back to it was excellent. On the strength of improved Q2 guidance published in a premarket PR, the stock made a healthy intraday move.

From a morning low of 1.66, MEET went on to hit an even 2.00 high toward the end of the session; a 20% swing. Volume was excessive, on the order of roughly 22x the 3-month average. Ideally, we need to see MEET maintain support at or above the new 200DMA of 1.74 on any pullbacks in order for us to remain interested.


The MaryJane Group, Inc. MJMJ

At the end of last week we were monitoring MJMJ for a bottom, After coming up off its bottom on Tuesday and providing us with a quality  opportunity, MJMJ continued to perform well with a nice intraday surge.

The stock made its way from an early low of .0036, and managed a subsequent high of .0055; a hefty 53% move.

From our observed low of .0027, we’ve seen an overall increase of 104% over a period of just a few sessions. With many cannabis stocks beginning to show increased signs of life lately, we’ll be sure to continue monitoring this play and others in the sector.


Cleveland BioLabs, Inc. CBLI

We want to keep an eye on CBLI after this morning’s big announcement (link below), which has essentially caused the stock to enter into Blue-Sky Breakout mode this morning, cracking through its 200DMA of 5.35 in the premarket. If it can maintain that 200DMA as support on an early pullback, we could see added increases.

Regardless, whenever we run across a stock in this position we’re always on the lookout for dip-and-rip scenarios to occur after a consolidation. It’s a pattern that we’ve seen played out time and time again.


Pazoo, Inc. PZOO

We also noticed a PR published on PZOO for the second consecutive day. After yesterday’s big announcement that the company had fully acquired MA & Associates’ marijuana testing business, today we learned that the company’s other subsidiary has signed a new, potentially lucrative distribution agreement.

Pazoo is another company that falls under the category of those doing everything they can to capitalize on the ever-expanding marijuana sector. It has remained extremely active in pursuing that goal over the entire time we’ve been tracking the stock.


Extended Watchlist:
RXMD, MHR, PTNT, RXII, BWEN, INVT

Blue Horseshoe Stocks: TPIV Recap, PZOO News & More

TapImmune, Inc. TPIV

Despite already being on one heck of a run, as we were stating in yesterday’s morning report, TPIV ended up having another landmark session in which it would surge to its highest PPS in almost a year.

The stock posted an early low of 1.20 before breaking out to 1.71, which registered as an intraday spike of 43% and occurred on heavy volume. TPIV also took the title of most actively-traded stock on the OTC for yesterday’s session, with shares changing hands 3,388 times.

We want to congratulate anyone who’s been tracking TPIV along with us recently; the total increase we’ve now observed in just eight sessions is equal to 137% (.72-1.71).

Yesterday’s continued uptrend was aided by the following PR:
TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients (Tue, Jun 23)


Pazoo, Inc. PZOO

Those of our subscribers that have joined our ranks in the past few weeks will need a little bringing up to speed on PZOO. We introduced this play at the beginning of April, and tracked it over an epic run from .0049 to .0204, which amounted to a 316% swing.

It has been nearly four weeks since we touched base with this play, and with a fresh PR released this morning, we think now would be a good time  to take another look. The stock has done well maintaining support throughout the month of June, trading in a channel between .009 to .011, holding a good bit of the advances we witnessed earlier in the Spring.

The storyline we’ve been following on PZOO of its 40% ownership in MA & associates, a Nevada-based marijuana testing agency, just got a whole lot more interesting with PZOO officially announcing that it has acquired the remaining 60% stake:

WHIPPANY, N.J., June 24, 2015 /PRNewswire/ – Pazoo, Inc. (OTC Pinks: PZOO) is pleased to report that on Wednesday, June 3, 2015,  Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo. >>FULL PR


The MaryJane Group, Inc. MJMJ

MJMJ was among several stocks we tagged for potential upcoming bottom-plays at the end of last week, and while it did take the call an extra session to materialize, it did end up making that rebound yesterday.

The stock traded in a range from .0027-.0038; which marks an intraday swing of 41% on more than twice the average monthly volume. We’ll continue to monitor activity in the stock as the week progresses.


Under Armour, Inc. UA – Options

Yesterday morning, we updated readers as to the performance of the 07/31 $84 Calls that we initially alerted on Friday. From our observed low of 2.76, these contracts pushed further upward yesterday, extending to a new high of 4.20.

That pushes the overall range we’ve witnessed in just a two-session span to a respectable 52% We’ll continue to stay attuned to the activity as long as UA continues to perform well.


Extended Watchlist:
CPXX, NSPR, MEET, GBSN,

Blue Horseshoe Stocks: CBDE, MCPI News & More

CBD Energy Ltd. CBDE

CBDE is a fairly new issuer, and built some serious momentum off of its bottom on Friday after the announcement of a lucrative solar farm construction contract. The company reports expected pre-tax revenues from the project amounting to more than $6 Million to be recognized in 2015, so we’re going to place this new stock on our medium-to-long term watchlist.

In the meantime, CBDE appears to be on the cusp of breaking the $4-mark this morning, which is the level at which the stock began trading just a couple of months ago. We’ll be watching for a breach of this psychological barrier, which would effectively put CBDE in Blue Sky mode, with no telling where the ceiling might come.

It should make for an interesting story to follow in the days and weeks ahead.


Med-Cannabis Pharma, Inc. MCPI

Turning focus to the marijuana space, we’ve got a new play to add to our running watchlist. It’s most interesting to us because it has a part to play in the implementation of legalization in Washington, which has been much more subdued than Colorado’s roll-out.

The madness that ensued thereafter led to months of record-breaking gains, but at the same time led to an SEC crackdown on what had become a free-for-all of false claims and hysteria. For that reason, companies involved in the more slowly unfolding Washington cannabis industry have been fewer and further between.

That’s exactly why we want to keep an eye on MCPI moving forward, despite the fact that it has already seen exponential gains; it’s confirmed that the company actually has boots on the ground in Washington, as indicated in this morning’s press release that we think you’ll want to check out:

PORT TOWNSEND, WA, Aug 04, 2014 (Marketwired via COMTEX) — Med-Cannabis Pharma, Inc. (OTCQB: MCPI), a Nevada Company specializing in Medical cannabis sales will be opening several Medical cannabis stores through its subsidiary Cannabis Hemporium in various towns on the Olympic Peninsula in the State of Washington during the month of August. The towns include Port Townsend, Port Hadlock and the Hood Canal location where work has been continuing for opening. >>> FULL PR


Side Note:

On Friday, we mentioned that we had an interest in PBR $16 Calls for this week, so we just wanted to remind readers that we would be focusing on those contracts as the trading week commences.


Extended Watchlist:
TSEM, NNVC, MEET, NQ, CAMT